Greiner Bio-One will be unveiling the CheckExtractor at EUROGIN 2011, a congress focusing on human papillomaviruses (HPV) and illnesses caused by HPV, such as cervical cancer.
EUROGIN will take place from 8 to 11 May in Lisbon, Portugal. The CheckExtractor enables automated DNA extraction and PCR setup for products in the oCheck product line of Greiner Bio-One, such as PapilloCheck high-risk for assessing the risk of cervical cancer.
The automated CheckExtractor extracts DNA from sample material. The advantages of automated DNA extraction for routine analysis are clear-cut – the procedure is accurate, reliable and requires only minimum hands-on time. Up to 288 samples can be processed per day.
The CheckExtractor is suitable for different types of sample vessels containing sensitive materials, such as swabs, blood and urine. A touchscreen enables intuitive operation. The sample vessels and reagents are scanned automatically via barcodes, making it possible to closely observe the extraction status of all samples at any time. The individual steps in the analysis process are managed and partly controlled by the Laboratory Information and Management System (LIMS).
What’s more, the CheckExtractor also enables automated PCR setup. During this process, samples are prepared so they only have to be taken from the machine and placed in the thermocycler. The CheckExtractor can be used for products in the oCheck product line, such as PapilloCheck high-risk. This DNA chip is used to determine high-risk HPV types, which can trigger cervical cancer.
